FDA.reportPublic FDA data

CELLTRION

NDC#

Vegzelma

CELLTRION USA, Inc.

bevacizumab-adcd

Vegzelma

CELLTRION USA, Inc.

bevacizumab-adcd

Yuflyma

CELLTRION USA, Inc.

adalimumab-aaty

Yuflyma

CELLTRION USA, Inc.

adalimumab-aaty

STEQEYMA

CELLTRION USA, Inc.

ustekinumab-stba

STEQEYMA

CELLTRION USA, Inc.

ustekinumab-stba

STEQEYMA

CELLTRION USA, Inc.

ustekinumab-stba

Yuflyma

CELLTRION USA, Inc.

adalimumab-aaty

Stoboclo

CELLTRION USA, Inc.

denosumab-bmwo

Osenvelt

CELLTRION USA, Inc.

denosumab-bmwo

Yuflyma

CELLTRION USA, Inc.

adalimumab-aaty

AVTOZMA

CELLTRION USA, Inc.

tocilizumab

AVTOZMA

CELLTRION USA, Inc.

tocilizumab

AVTOZMA

CELLTRION USA, Inc.

tocilizumab

AVTOZMA

CELLTRION USA, Inc.

tocilizumab

Yuflyma

CELLTRION USA, Inc.

adalimumab-aaty

STEQEYMA

CELLTRION USA, Inc.

ustekinumab-stba

Yuflyma

CELLTRION USA, Inc.

adalimumab-aaty

Applications#